{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:44:41Z","timestamp":1765485881664,"version":"3.41.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI101772"],"award-info":[{"award-number":["AI101772"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The University of Texas Medical Branch"},{"name":"NIH Post-Baccalaureate Research Education Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.virusres.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T02:14:02Z","timestamp":1432692842000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates"],"prefix":"10.1016","volume":"216","author":[{"given":"Kaori","family":"Terasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breanna R.","family":"Tercero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 4","key":"10.1016\/j.virusres.2015.05.012_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1099\/0022-1317-82-4-781","article-title":"Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates","volume":"82","author":"Accardi","year":"2001","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2015.05.012_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0882-4010(87)90126-4","article-title":"Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats","volume":"2","author":"Anderson","year":"1987","journal-title":"Microb. Pathog."},{"issue":"1\u20134","key":"10.1016\/j.virusres.2015.05.012_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01316748","article-title":"Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies","volume":"121","author":"Besselaar","year":"1991","journal-title":"Arch. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2015.05.012_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0923-2516(91)90069-F","article-title":"Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains","volume":"142","author":"Besselaar","year":"1991","journal-title":"Res. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2015.05.012_bib0025","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pntd.0000725","article-title":"Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing Gn protects mice against Rift Valley fever virus","volume":"4","author":"Bhardwaj","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virusres.2015.05.012_bib0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"Am. Vet. Med. Assoc."},{"issue":"24","key":"10.1016\/j.virusres.2015.05.012_bib0045","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, non-teratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"Bird","year":"2011","journal-title":"J. Virol."},{"issue":"27","key":"10.1016\/j.virusres.2015.05.012_bib0050","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1016\/j.vaccine.2011.04.043","article-title":"A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(\u2212\/\u2212) mice upon lethal virus challenge","volume":"29","author":"Boshra","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.virusres.2015.05.012_bib0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2015.05.012_bib0060","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus non-structural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"issue":"Pt 10","key":"10.1016\/j.virusres.2015.05.012_bib0065","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.05.012_bib0070","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"issue":"11","key":"10.1016\/j.virusres.2015.05.012_bib0075","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"de Boer","year":"2010","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.virusres.2015.05.012_bib0080","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan sulfate facilitates Rift Valley fever virus entry into the cell","volume":"86","author":"de Boer","year":"2012","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virusres.2015.05.012_bib0085","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein","volume":"86","author":"de Boer","year":"2012","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2015.05.012_bib0090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.1217780110","article-title":"Crystal structure of glycoprotein C from Rift Valley fever virus","volume":"110","author":"Dessau","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.virusres.2015.05.012_bib0095","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/JVI.07104-11","article-title":"Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge","volume":"86","author":"Dodd","year":"2012","journal-title":"J. Virol."},{"issue":"29","key":"10.1016\/j.virusres.2015.05.012_bib0100","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.virusres.2015.05.012_bib0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2006.07.035","article-title":"Development and characterization of a Rift Valley fever virus cell\u2013cell fusion assay using alphavirus replicon vectors","volume":"356","author":"Filone","year":"2006","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.virusres.2015.05.012_bib0110","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1128\/JVI.01191-08","article-title":"Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography","volume":"82","author":"Freiberg","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.05.012_bib0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4682-1-10","article-title":"Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)","volume":"1","author":"Garry","year":"2004","journal-title":"Theor. Biol. Med. Model."},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virusres.2015.05.012_bib0125","doi-asserted-by":"crossref","first-page":"e1421","DOI":"10.1371\/journal.pntd.0001421","article-title":"Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice","volume":"5","author":"Gommet","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"Pt 9","key":"10.1016\/j.virusres.2015.05.012_bib0130","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","article-title":"T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus","volume":"89","author":"Habjan","year":"2008","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.011","article-title":"Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses","volume":"385","author":"Habjan","year":"2009","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virusres.2015.05.012_bib0140","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virusres.2015.05.012_bib0145","doi-asserted-by":"crossref","first-page":"12954","DOI":"10.1128\/JVI.02242-12","article-title":"Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis","volume":"86","author":"Harmon","year":"2012","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2015.05.012_bib0150","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep","volume":"41","author":"Harrington","year":"1980","journal-title":"Am. J. Vet. Res."},{"issue":"9","key":"10.1016\/j.virusres.2015.05.012_bib0155","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1017\/S0950268808001696","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","volume":"137","author":"Heise","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virusres.2015.05.012_bib0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fpubh.2014.00169","article-title":"Recent outbreaks of rift valley Fever in East Africa and the middle East","volume":"2","author":"Himeidan","year":"2014","journal-title":"Front. Public Health"},{"issue":"11","key":"10.1016\/j.virusres.2015.05.012_bib0165","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/CVI.00182-09","article-title":"A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity","volume":"16","author":"Holman","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.virusres.2015.05.012_bib0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The Pathogenesis of Rift Valley Fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0175","doi-asserted-by":"crossref","first-page":"e1000287","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation","volume":"5","author":"Ikegami","year":"2009","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.virusres.2015.05.012_bib0180","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1128\/JVI.79.9.5606-5615.2005","article-title":"Rift valley fever virus non-structural protein NSs promotes viral RNA replication and transcription in a minigenome system","volume":"79","author":"Ikegami","year":"2005","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2015.05.012_bib0185","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.05.012_bib0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1875035401003010114","article-title":"Evaluation of a recombinant Rift Valley fever virus subunit nucleocapsid protein as an immunogen in mice and sheep","volume":"3","author":"Jansen van Vuren","year":"2010","journal-title":"Open Vaccine J."},{"key":"10.1016\/j.virusres.2015.05.012_bib0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"Kamal","year":"2009","journal-title":"Virol. J."},{"issue":"23","key":"10.1016\/j.virusres.2015.05.012_bib0200","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.virusres.2015.05.012_bib0205","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.virusres.2015.05.012_bib0210","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a non-spreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J. Virol."},{"issue":"e71","key":"10.1016\/j.virusres.2015.05.012_bib0215","article-title":"The Rift Valley fever accessory proteins NSm and P78\/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts","volume":"3","author":"Kreher","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.virusres.2015.05.012_bib0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.virusres.2015.05.012_bib0225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0230","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells","volume":"4","author":"Le May","year":"2008","journal-title":"PLoS Pathog."},{"issue":"14","key":"10.1016\/j.virusres.2015.05.012_bib0235","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/JVI.00778-12","article-title":"The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine","volume":"86","author":"Lihoradova","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.05.012_bib0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-5-82","article-title":"Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins","volume":"5","author":"Liu","year":"2008","journal-title":"Virol. J."},{"issue":"24","key":"10.1016\/j.virusres.2015.05.012_bib0245","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1128\/JVI.02081-12","article-title":"Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains","volume":"86","author":"Lokugamage","year":"2012","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2015.05.012_bib0250","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"Lopez-Gil","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"7","key":"10.1016\/j.virusres.2015.05.012_bib0255","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1128\/JVI.69.7.3972-3979.1995","article-title":"The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules","volume":"69","author":"Lopez","year":"1995","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virusres.2015.05.012_bib0260","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(\u2212\/\u2212) mice induced by different DNA vaccination regimens","volume":"28","author":"Lorenzo","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"Mandell","year":"2010","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virusres.2015.05.012_bib0275","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.virusres.2015.05.012_bib0280","doi-asserted-by":"crossref","first-page":"e2746","DOI":"10.1371\/journal.pntd.0002746","article-title":"Development of a novel, single-cycle replicable Rift Valley fever vaccine","volume":"8","author":"Murakami","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley fever virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/inf.1982.14.issue-2.06","article-title":"Rift Valley fever virus vaccine trial: study of side-effects in humans","volume":"14","author":"Niklasson","year":"1982","journal-title":"Scand. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2015.05.012_bib0295","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0264-410X(85)90061-1","article-title":"Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans","volume":"3","author":"Niklasson","year":"1985","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virusres.2015.05.012_bib0300","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"Niklasson","year":"1984","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. C"},{"issue":"5","key":"10.1016\/j.virusres.2015.05.012_bib0305","doi-asserted-by":"crossref","first-page":"e93483","DOI":"10.1371\/journal.pone.0093483","article-title":"Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors","volume":"9","author":"Nuss","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.virusres.2015.05.012_bib0310","doi-asserted-by":"crossref","first-page":"e77461","DOI":"10.1371\/journal.pone.0077461","article-title":"A single vaccination with an improved non-spreading Rift Valley fever virus vaccine provides sterile immunity in lambs","volume":"8","author":"Oreshkova","year":"2013","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1016\/j.virusres.2015.05.012_bib0315","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/JVI.02655-06","article-title":"The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging","volume":"81","author":"Overby","year":"2007","journal-title":"J. Virol."},{"issue":"36","key":"10.1016\/j.virusres.2015.05.012_bib0320","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1073\/pnas.1112149108","article-title":"Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice","volume":"108","author":"Papin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.virusres.2015.05.012_bib0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01311021","article-title":"Experimental Rift Valley fever in rhesus macaques","volume":"99","author":"Peters","year":"1988","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2015.05.012_bib0330","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res."},{"issue":"7","key":"10.1016\/j.virusres.2015.05.012_bib0335","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2009.0248","article-title":"Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus","volume":"10","author":"Pichlmair","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"3","key":"10.1016\/j.virusres.2015.05.012_bib0340","doi-asserted-by":"crossref","first-page":"e18070","DOI":"10.1371\/journal.pone.0018070","article-title":"Efficient cellular release of Rift Valley fever virus requires genomic RNA","volume":"6","author":"Piper","year":"2011","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.virusres.2015.05.012_bib0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2015.05.012_bib0350","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall","year":"1962","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2015.05.012_bib0355","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/emi.2013.81","article-title":"The risk of Rift Valley fever virus introduction and establishment in the United States and European Union","volume":"2","author":"Rolin","year":"2013","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.virusres.2015.05.012_bib0360","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0365","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"issue":"8173","key":"10.1016\/j.virusres.2015.05.012_bib0370","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(80)91395-1","article-title":"Serological relation between Rift Valley fever virus and viruses of Phlebotomus fever serogroup","volume":"1","author":"Shope","year":"1980","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0375","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol."},{"issue":"21","key":"10.1016\/j.virusres.2015.05.012_bib0380","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2015.05.012_bib0385","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4269\/ajtmh.1982.31.149","article-title":"Studies on the antigenic relationship among phleboviruses","volume":"31","author":"Tesh","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.virusres.2015.05.012_bib0390","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2987\/08-5791.1","article-title":"Potential for North American mosquitoes to transmit Rift Valley fever virus","volume":"24","author":"Turell","year":"2008","journal-title":"J. Am. Mosq. Control Assoc."},{"issue":"5","key":"10.1016\/j.virusres.2015.05.012_bib0395","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jmedent\/47.5.884","article-title":"Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus","volume":"47","author":"Turell","year":"2010","journal-title":"J. Med. Entomol."},{"issue":"34","key":"10.1016\/j.virusres.2015.05.012_bib0400","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"von Teichman","year":"2011","journal-title":"Vaccine"},{"issue":"49\u201350","key":"10.1016\/j.virusres.2015.05.012_bib0405","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"issue":"Pt 11","key":"10.1016\/j.virusres.2015.05.012_bib0410","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.035105-0","article-title":"Recent advances in the molecular and cellular biology of bunyaviruses","volume":"92","author":"Walter","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.05.012_bib0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-10-349","article-title":"Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice","volume":"10","author":"Warimwe","year":"2013","journal-title":"Virol. J."},{"issue":"18","key":"10.1016\/j.virusres.2015.05.012_bib0420","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1128\/JVI.00961-14","article-title":"Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging","volume":"88","author":"Wichgers Schreur","year":"2014","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virusres.2015.05.012_bib0425","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1128\/JVI.00476-06","article-title":"NSm and 78-kilodalton proteins of Rift Valley fever virus are non-essential for viral replication in cell culture","volume":"80","author":"Won","year":"2006","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2015.05.012_bib0430","doi-asserted-by":"crossref","first-page":"e59210","DOI":"10.1371\/journal.pone.0059210","article-title":"The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses","volume":"8","author":"Xu","year":"2013","journal-title":"PLOS ONE"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215001999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215001999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:26:17Z","timestamp":1748402777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170215001999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":86,"alternative-id":["S0168170215001999"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2015.05.012","relation":{},"ISSN":["0168-1702"],"issn-type":[{"type":"print","value":"0168-1702"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}